Absci

Absci is a company that specializes in the development and utilization of artificial intelligence and synthetic biology to transform drug discovery and manufacturing processes. The company's proprietary technologies, including its SoluPro™, E.coli manufacturing platform, and the Absci Conjugate Discovery Platform™, assist in the creation of complex proteins and the discovery of novel bioconjugates. These platforms serve to streamline the traditionally long process of drug discovery, accelerating the path to market for new therapies.

The company, established in 2011, has its headquarters in Vancouver, Washington. Over the years, Absci has grown to become a valuable partner for pharmaceutical and biotech companies by providing them with a more efficient way of developing drugs. By integrating AI and machine learning into the drug discovery process, Absci aims to predict, produce, and purify novel biotherapeutics, helping companies to reduce the time and costs associated with drug development.